Navigation Links
St. Jude Medical to Expand Puerto Rico Operations
Date:9/19/2007

With purchase of Arecibo plant, St. Jude Medical will add up to 1,200 new jobs within 36 months of initiating operations in its second facility in

Puerto Rico

ARECIBO, Puerto Rico, Sept. 19 /PRNewswire-FirstCall/ -- St. Jude Medical, Inc. (NYSE: STJ) today announced plans to expand its operations in Puerto Rico. St. Jude Medical recently purchased a facility in Arecibo's Santana Industrial Park, which will allow the company to increase its Puerto Rico operations by 30 percent and create up to 1,200 new jobs within the next three years.

The facility is expected to begin operating by mid-year 2008. Initially, St. Jude Medical in Arecibo will produce cardiac rhythm management devices, including pacemakers and pacing leads, which are currently produced at the company's Caguas plant. In addition, St. Jude Medical plans to begin manufacturing implantable cardioverter defibrillators (ICDs) and their corresponding high voltage leads at the Arecibo site at a later date.

The Caguas site will continue to manufacture mechanical heart valves and Angio-Seal(TM) vascular closure devices, and also is expected to add new product lines in the future.

"St. Jude Medical's success in Puerto Rico over the past 20 years has been the result of our local team's commitment to upholding the highest standards for quality and manufacturing excellence," said Daniel J. Starks, St. Jude Medical chairman, president and chief executive officer. "Quality is our top priority because our devices are life-saving for many thousands of patients around the world."

St. Jude Medical began operations in Puerto Rico with 25 employees at its current Caguas facility in 1987. The original 23,000 square-foot plant, which manufactured mechanical heart valves, has evolved with the company's continuous development of new cardiovascular products, tripling its size and expanding its scope to manufacture more than 220 models of cardiovascular and cardiac rhythm management products that are exported to countries around the world.

"St. Jude Medical Puerto Rico, B. V. employs some of the most advanced technologies and talented people available in our industry to produce top quality medical devices and products. The expansion plans we unveiled today will further enhance the competitiveness of our operations on the island," said Angel L. Ortiz, general manager of St. Jude Medical Puerto Rico, B. V., who currently oversees Puerto Rico operations in both Arecibo and Caguas.

In addition to this expansion, in January 2007 St. Jude Medical opened a sales office in Caguas. This office has specially-trained representatives who provide sales, service and technical support to assist physicians, nursing staffs, hospitals and patients using St. Jude Medical's products in Puerto Rico and the Caribbean.

About St. Jude Medical

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 12,000 people worldwide. For more information, please visit http://www.sjm.com.


'/>"/>
SOURCE St. Jude Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):